Analyst Moves: CLX, GPS

This morning, Morgan Stanley downgraded shares of Clorox (CLX) from equal weight to underweight citing valuation. The stock has climbed past the firm's $ 63 price target and is overvalued currently. This morning, Morgan Stanley downgraded shares of
See all stories on this topic »
Google Alerts – intitle:gps -intext:Gap -intext:GP -intext:health -intext:doctor

Note: Newswire stories are provided as a courtesy of Rated4Stars.com. Content of these articles is provided by external sources.

uSell

Speak Your Mind